Zhitong Finance App News, Haizheng Pharmaceutical (600267.SH) issued an announcement. On December 12, 2024, the company participated in the bidding process for the 10th batch of centralized national drug procurement organized by the Joint Procurement Office (“Joint Procurement Office”). After the joint procurement office opened and evaluated the bid, the company's products, apamistel tablets and posaconazole enteric tablets, were to win the bid for this centralized procurement. Apamistel tablets and posaconazole enteric tablets have been selected by the supplier provinces based on the market potential of each province, and the selection results will be officially released after the joint procurement office shows.

This centralized drug procurement is the tenth batch of national drug procurement organized by the state. In terms of implementation, medical institutions across the country are required to prioritize the use of selected varieties from centralized procurement and ensure that the agreed procurement volume is completed. If the varieties to be selected by the company this time are determined and implemented, it will help the above products to quickly open up the domestic sales market, increase market share, promote the further development of the company's formulation business, and enhance the company's brand influence.